Suppr超能文献

一种用于抑制噬菌体抗性出现的噬菌体鸡尾酒的开发

Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant .

作者信息

Yang Yuhui, Shen Wei, Zhong Qiu, Chen Qian, He Xuesong, Baker Jonathon L, Xiong Kun, Jin Xiaoling, Wang Jing, Hu Fuquan, Le Shuai

机构信息

Department of Microbiology, Army Medical University, Chongqing, China.

Department of Medical Laboratory, The General Hospital of Western Theater Command, Chengdu, China.

出版信息

Front Microbiol. 2020 Mar 4;11:327. doi: 10.3389/fmicb.2020.00327. eCollection 2020.

Abstract

With the emergence of multidrug-resistant and extensively drug-resistant bacterial pathogens, phage therapy and other alternative or additional therapeutic modalities are receiving resurgent attention. One of the major obstacles in developing effective phage therapies is the evolution of phage resistance in the bacterial host. When was infected with a phage that uses O-antigen as receptor, phage resistances typically achieved through changing or loss of O-antigen structure. In this study, we showed that dsRNA phage phiYY uses core lipopolysaccharide as receptor and therefore efficiently kills the O-antigen deletion mutants. Furthermore, by phage training, we obtained PaoP5-m1, a derivative of dsDNA phage PaoP5, which is able to infect mutants with truncated O-antigen. We then generated a cocktail by mixing phiYY and PaoP5-m1 with additional three wide host range phages. The phage cocktail was effective against a diverse selection of clinical isolates of , and in the short-term constrained the appearance of the phage-resistant mutants that had beleaguered the effectiveness of single phage. Resistance to the 5-phage cocktail emerges after several days, and requires mutations in both and Thus, this study provides an alternative strategy for designing phage cocktail and phage therapy.

摘要

随着多重耐药和广泛耐药细菌病原体的出现,噬菌体疗法及其他替代或辅助治疗方式正重新受到关注。开发有效的噬菌体疗法的主要障碍之一是细菌宿主中噬菌体抗性的演变。当细菌被以O抗原为受体的噬菌体感染时,噬菌体抗性通常通过改变或缺失O抗原结构来实现。在本研究中,我们表明双链RNA噬菌体phiYY以核心脂多糖为受体,因此能有效杀死O抗原缺失突变体。此外,通过噬菌体驯化,我们获得了双链DNA噬菌体PaoP5的衍生物PaoP5-m1,它能够感染O抗原截短的突变体。然后,我们将phiYY和PaoP5-m1与另外三种广宿主范围的噬菌体混合制成了一种噬菌体混合物。该噬菌体混合物对多种临床分离的细菌有效,并且在短期内抑制了困扰单一噬菌体有效性的噬菌体抗性突变体的出现。对这种5噬菌体混合物的抗性在几天后出现,并且需要细菌的两个基因发生突变。因此,本研究为设计噬菌体混合物和噬菌体疗法提供了一种替代策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1c0/7065532/f1e5a645a925/fmicb-11-00327-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验